PLx Pharma Analysis
| PLXPDelisted Stock | USD 0 0.00 0.00% |
PLx Pharma is overvalued with Real Value of 0.0038 and Hype Value of 0.005. The main objective of PLx Pharma delisted stock analysis is to determine its intrinsic value, which is an estimate of what PLx Pharma is worth, separate from its market price. There are two main types of PLx Pharma's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect PLx Pharma's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of PLx Pharma's stock to identify patterns and trends that may indicate its future price movements.
The PLx Pharma stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. PLx Pharma is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. PLx Stock trading window is adjusted to America/New York timezone. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and PLx Pharma's ongoing operational relationships across important fundamental and technical indicators.
PLx |
PLx Stock Analysis Notes
About 15.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.58. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. PLx Pharma recorded a loss per share of 0.39. The entity last dividend was issued on the 20th of April 2017. The firm had 1:8 split on the 20th of April 2017. PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey. Plx Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 16 people. To find out more about PLx Pharma contact David Luci at 973 409 6541 or learn more at https://plxpharma.com.PLx Pharma Investment Alerts
Many investors view ongoing market volatility as an opportunity to purchase more delisted stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. PLx Pharma's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding PLx Pharma or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
| PLx Pharma is not yet fully synchronised with the market data | |
| PLx Pharma has some characteristics of a very speculative penny stock | |
| PLx Pharma has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 8.21 M. Net Loss for the year was (46.12 M) with profit before overhead, payroll, taxes, and interest of 3.4 M. | |
| PLx Pharma currently holds about 35.73 M in cash with (32.12 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.27, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 15.0% of the company outstanding shares are owned by corporate insiders |
PLx Pharma Upcoming and Recent Events
Earnings reports are used by PLx Pharma to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to PLx Pharma previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 24th of March 2023 Upcoming Quarterly Report | View | |
| 31st of December 2022 Next Fiscal Quarter End | View |
PLx Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.53 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate PLx Pharma's market, we take the total number of its shares issued and multiply it by PLx Pharma's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.PLx Pharma Predictive Daily Indicators
PLx Pharma intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of PLx Pharma stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
About PLx Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how PLx Pharma prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling PLx shares will generate the highest return on investment. We also built our delisted stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Delisted Stock such as PLx Pharma. By using and applying PLx Stock analysis, traders can create a robust methodology for identifying PLx entry and exit points for their positions.
PLx Pharma Inc. operates as a commercial-stage drug delivery platform technology company in the United States. PLx Pharma Inc. was incorporated in 2002 and is headquartered in Sparta, New Jersey. Plx Pharma operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 16 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding PLx Pharma to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Analyst Advice Now
Analyst AdviceAnalyst recommendations and target price estimates broken down by several categories |
| All Next | Launch Module |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Other Consideration for investing in PLx Stock
If you are still planning to invest in PLx Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the PLx Pharma's history and understand the potential risks before investing.
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |